Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

J. Löfblom, J. Feldwisch, V. Tolmachev, J. Carlsson, S. Ståhl, F. Y. Frejd

Результат исследований: Материалы для журналаОбзорная статьярецензирование

413 Цитирования (Scopus)

Аннотация

Affibody molecules are a class of engineered affinity proteins with proven potential for therapeutic, diagnostic and biotechnological applications. Affibody molecules are small (6.5. kDa) single domain proteins that can be isolated for high affinity and specificity to any given protein target. Fifteen years after its discovery, the Affibody technology is gaining use in many groups as a tool for creating molecular specificity wherever a small, engineering compatible tool is warranted. Here we summarize recent results using this technology, propose an Affibody nomenclature and give an overview of different HER2-specific Affibody molecules. Cumulative evidence suggests that the three helical scaffold domain used as basis for these molecules is highly suited to create a molecular affinity handle for vastly different applications.

Язык оригиналаАнглийский
Страницы (с-по)2670-2680
Число страниц11
ЖурналFEBS Letters
Том584
Номер выпуска12
DOI
СостояниеОпубликовано - июн 2010
Опубликовано для внешнего пользованияДа

ASJC Scopus subject areas

  • Biophysics
  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Fingerprint Подробные сведения о темах исследования «Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications». Вместе они формируют уникальный семантический отпечаток (fingerprint).

Цитировать